New Delhi – India's Civil Aviation Ministry is exploring the implementation of mandatory drug testing for all commercial airline pilots. This move comes in the wake of an incident on August 4, where a pilot from an Air India flight tested positive for psychoactive substances in a preliminary screening.
The incident involved an Air India Phuket-Delhi flight which experienced a sudden loss of altitude, resulting in injuries to several passengers. Civil Aviation Minister Ram Mohan Naidu confirmed that the Centre is deliberating expanding the current drug testing protocols to cover all pilots.
Current Regulations and Proposed Changes
Under the existing Civil Aviation Requirements (CAR), only 10% of flight crew members and air traffic controllers are subjected to random drug tests. The ministry's proposal aims to significantly broaden this scope, potentially making India the first country globally to mandate such comprehensive testing for all commercial pilots.
Minister Naidu emphasized the need to balance aviation safety with the operational impact on airlines. The Directorate General of Civil Aviation (DGCA) is currently assessing the implications of this expanded requirement. India presently has over 11,000 active commercial pilots, with an estimated total of 25,000 pilots overall.
Substances Under Scrutiny
The substances covered under the current drug testing regulations include a range of psychoactive compounds. These are amphetamine and amphetamine-type stimulants, opiates and their metabolites, cannabis (THC), cocaine, barbiturates, and benzodiazepines.
Should an employee yield a non-negative screening result, they are immediately removed from safety-sensitive duties. This removal remains in effect until a confirmatory report is received, ensuring no pilot under suspicion operates an aircraft during this period. The recent Air India pilot's positive preliminary result, though awaiting official confirmation, has underscored the urgency for a more rigorous testing regime.